Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03597009
Title A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

lung cancer

Therapies

Nivolumab + Talimogene laherparepvec

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.